Progesterone alters Nogo-A, GFAP and GAP-43 expression in a rat model of traumatic brain injury

Molecular Medicine Reports

Volumn 9, Issue 4, 2014, Pages 1225-1231

  Liu, Feng ^a   Liao, Fan ^a   Li, Wei ^b   Han, Yongfeng ^c   Liao, Daguang ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b First Hospital of Changsha   (China)

^c FIRST HOSPITAL OF SHIJIAZHUANG   (China)

Author keywords

GAP 43; GFAP; Nogo A; Progesterone; Traumatic brain injury

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROMODULIN; PROGESTERONE; PROTEIN NOGO A;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFICACY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MALE; MOLECULE; NERVE CELL GROWTH; NERVE CELL PLASTICITY; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; SHAM PROCEDURE; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GAP-43 PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; MALE; MYELIN PROTEINS; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84896512685     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1967     Document Type: Article

References (46)

1. Asemota AO, George BP, Bowman SM, Haider AH and Schneider EB: Causes and trends in traumatic brain injury for United States adolescents. J Neurotrauma 30: 67-75, 2013.
2. Feeser VR and Loria RM: Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions. J Neuroimmunol 237: 4-12, 2011.
3. Gibson CL, Gray LJ, Bath PM and Murphy SP: Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131: 318-328, 2008. (Pubitemid 351197603)
4. Roof RL, Duvdevani R, Braswell L and Stein DG: Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 129: 64-69, 1994. (Pubitemid 24344157)
5. Roof RL, Duvdevani R and Stein DG: Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor Neurol Neurosci 4: 425-427, 1992. (Pubitemid 23001029)
6. Gibson CL, Constantin D, Prior MJ, Bath PM and Murphy SP: Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol 193: 522-530, 2005. (Pubitemid 40616199)
7. Horner PJ and Gage FH: Regenerating the damaged central nervous system. Nature 407: 963-970, 2000.
8. Xiong NX, Zhao HY, Zhang FC and He ZQ: Negative correlation of Nogo-A with the malignancy of oligodendroglial tumor. Neurosci Bull 23: 41-45, 2007.
9. Hsieh SH, Ferraro GB and Fournier AE: Myelin-associated inhibitors regulate cofilin phosphorylation and neuronal inhibition through LIM kinase and Slingshot phosphatase. J Neurosci 26: 1006-1015, 2006. (Pubitemid 43237092)
10. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL and He Z: Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417: 941-944, 2002. (Pubitemid 34716869)
11. Yiu G and He Z: Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 7: 617-627, 2006. (Pubitemid 44106744)
12. Fitch MT and Silver J: CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 209: 294-301, 2008. (Pubitemid 351174127)
13. Brenneman MM, Wagner SJ, Cheatwood JL, Heldt SA, Corwin JV, Reep RL, Kartje GL, Mir AK and Schwab ME: Nogo-A inhibition induces recovery from neglect in rats. Behav Brain Res 187: 262-272, 2008.
14. Wang H, Yao YJ and Chen DP: Expression of Nogo-A mRNA and Nogo-A protein in brain tissue of neonatal mice with ischemic-hypoxic brain damage. Zhonghua Er Ke Za Zhi 44: 792-793, 2006 (In Chinese).
15. Stichel CC and Müller HW: The CNS lesion scar: new vistas on an old regeneration barrier. Cell Tissue Res 294: 1-9, 1998. (Pubitemid 28442277)
16. Clayton GH, Mahalik TJ and Finger TE: Expression of GAP43 mRNA in normally developing and transplanted neurons from the rat ventral mesencephalon. J Comp Neurol 347: 470-480, 1994. (Pubitemid 24279014)
17. Denny JB: Molecular mechanisms, biological actions, and neuro-pharmacology of the growth-associated protein GAP-43. Curr Neuropharmacol 4: 293-304, 2006.
18. Benowitz LI and Routtenberg A: GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20: 84-91, 1997. (Pubitemid 27050703)
19. Donovan SL and McCasland JS: GAP-43 is critical for normal targeting of thalamocortical and corticothalamic, but not trigeminothalamic axons in the whisker barrel system. Somatosens Mot Res 25: 33-47, 2008. (Pubitemid 351398387)
20. Hughes-Davis EJ, Cogen JP, Jakowec MW, Cheng HW, Grenningloh G, Meshul CK and McNeill TH: Differential regulation of the growth-associated proteins GAP-43 and superior cervical ganglion 10 in response to lesions of the cortex and substantia nigra in the adult rat. Neuroscience 135: 1231-1239, 2005. (Pubitemid 41416684)
21. Nagamoto-Combs K, Morecraft RJ, Darling WG and Combs CK: Long-term gliosis and molecular changes in the cervical spinal cord of the rhesus monkey after traumatic brain injury. J Neurotrauma 27: 565-585, 2010.
22. Schmidt-Kastner R, Bedard A and Hakim A: Transient expression of GAP-43 within the hippocampus after global brain ischemia in rat. Cell Tissue Res 288: 225-238, 1997. (Pubitemid 27187061)
23. Labombarda F, González Deniselle MC, De Nicola AF and González SL: Progesterone and the spinal cord: good friends in bad times. Neuroimmunomodulation 17: 146-149, 2010.
24. Garay L, Deniselle MC, Meyer M, Costa JJ, Lima A, Roig P and De nicola AF: Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis. Brain Res 1283: 177-185, 2009.
25. De Nicola AF, Labombarda F, Deniselle MC, Gonzalez SL, Garay L, Meyer M, Gargiulo G, Guennoun R and Schumacher M: Progesterone neuroprotection in traumatic CNS injury and moto-neuron degeneration. Front Neuroendocrinol 30: 173-187, 2009.
26. Feeney DM, Boyeson MG, Linn RT, Murray HM and Dail WG: Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 211: 67-77, 1981. (Pubitemid 11147211)
27. Goss CW, Hoffman SW and Stein DG: Behavioral effects and anatomic correlates after brain injury: a progesterone dose ?response study. Pharmacol Biochem Behav 76: 231-242, 2003. (Pubitemid 37329844)
28. Anderson GD, Farin FM, Bammler TK, Beyer RP, Swan AA, Wilkerson HW, Kantor ED and Hoane MR: The effect of progesterone dose on gene expression after traumatic brain injury. J Neurotrauma 28: 1827-1843, 2011.
29. Pajović SB, Saicić ZS, Spasić MB, Petrović VM and Martinović JV: Effects of progesterone and estradiol benzoate on glutathione dependent antioxidant enzyme activities in the brain of female rats. Gen Physiol Biophys 18: 35-44, 1999.
30. Pierson RC, Lyons AM and Greenfield LJ, Jr: Gonadal steroids regulate GABAA receptor subunit mRNA expression in NT2-N neurons. Brain Res Mol Brain Res 138: 105-115, 2005. (Pubitemid 41138029)
31. GrandPré T, Nakamura F, Vartanian T and Strittmatter SM: Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403: 439-444, 2000. (Pubitemid 30073094)
32. Oertle T, van der Haar ME, Bandtlow CE, et al: Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 23: 5393-5406, 2003. (Pubitemid 36807813)
33. Marklund N, Bareyre FM, Royo NC, Thompson HJ, Mir AK, Grady MS, Schwab ME and McIntosh TK: Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. J Neurosurg 107: 844-853, 2007. (Pubitemid 47547752)
34. Lenzlinger PM, Shimizu S, Marklund N, et al: Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats. Neuroscience 134: 1047-1056, 2005. (Pubitemid 41133405)
35. Mueller BK, Mueller R and Schoemaker H: Stimulating neuro-regeneration as a therapeutic drug approach for traumatic brain injury. Br J Pharmacol 157: 675-685, 2009.
36. Gonzalez Deniselle MC, Lopez Costa JJ, Gonzalez SL, Labombarda F, Garay L, Guennoun R, Schumacher M and De Nicola AF: Basis of progesterone protection in spinal cord neurodegeneration. J Steroid Biochem Mol Biol 83: 199-209, 2002. (Pubitemid 37045352)
37. Schreyer DJ and Skene JH: Injury-associated induction of GAP-43 expression displays axon branch specificity in rat dorsal root ganglion neurons. J Neurobiol 24: 959-970, 1993. (Pubitemid 23178785)
38. Hulsebosch CE, DeWitt DS, Jenkins LW and Prough DS: Traumatic brain injury in rats results in increased expression of Gap-43 that correlates with behavioral recovery. Neurosci Lett 255: 83-86, 1998. (Pubitemid 28494204)
39. Santoro B, Bigini P, Levandis G, Nobile V, Biggiogera M, Botti F, Mennini T and Curti D: Evidence for chronic mitochondrial impairment in the cervical spinal cord of a murine model of motor neuron disease. Neurobiol Dis 17: 349-357, 2004. (Pubitemid 39345790)
40. González Deniselle MC, González SL and De Nicola AF: Cellular basis of steroid neuroprotection in the wobbler mouse, a genetic model of motoneuron disease. Cell Mol Neurobiol 21: 237-254, 2001. (Pubitemid 32852778)
41. Udvadia AJ, Köster RW and Skene JH: GAP-43 promoter elements in transgenic zebrafish reveal a difference in signals for axon growth during CNS development and regeneration. Development 128: 1175-1182, 2001. (Pubitemid 32405239)
42. Nguyen L, He Q and Meiri KF: Regulation of GAP-43 at serine 41 acts as a switch to modulate both intrinsic and extrinsic behaviors of growing neurons, via altered membrane distribution. Mol Cell Neurosci 41: 62-73, 2009.
43. Cutler SM, VanLandingham JW, Murphy AZ and Stein DG: Slow-release and injected progesterone treatments enhance acute recovery after traumatic brain injury. Pharmacol Biochem Behav 84: 420-428, 2006. (Pubitemid 44292244)
44. Wali B, Sayeed I and Stein DG: Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor Neurol Neurosci 29: 61-71, 2011.
45. Wright DW, Kellermann AL, Hertzberg VS, et al: ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 49: 391-402, 2007.
46. Xiao G, Wei J, Yan W, Wang W and Lu Z: Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 12: R61, 2008.